PDF-Guidance for Industry and FDA Staff Submissions for Postapproval Modifications to a Combination

Comments and suggestions regarding this draft document should be submitted within 90 days of publication in the Federal Register of the notice announcing the availability of the draft guidance Submit written comments to the Di vision of Dockets Mana. 574115745557453574535744557454574605745957376574415745457444573765745957461574475744757445574595746057449574555745457459573765745857445574475744157458574445744957454574475737657460574485744957459573765744457458574415744657460573765744457455574435746 Comments and suggestions regarding this draft document should be submitted within 60 days of publication in the Federal Register of the notice announcing the availability of the draft guidance Submit electronic comments to httpwwwregulationsgov Sub Comments and suggestions regarding this draft document should be submitted within 60 days of publication in the Federal Register of the notice announcing the availability of the draft guidance Submit electronic comments to httpwwwregulationsgov Sub Comments and suggestions regarding this draft document should be submitted within 90 days of publication in the Federal Register of the notice announcing the availability of the draft guidance Submit electronic comments to httpwwwregulationsgov Sub Comments and suggestions regarding this draft document should be submitted within 60 days of publication in the Federal Register of the notice announcing the availability of the draft guidance Submit electronic comments on the draft guidance to http Comments and suggestions regarding this draft document should be submitted within 60 calendar days of publication in the Federal Register of the notice announcing the availability of the draft guidance Submit comments to the Division of Dockets Mana Federal Register Federal Register US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research CDER January 2010 Clinical Medical brPage 2br Guidance for Industry Assessment of Abuse Potential of Dr Com ents and suggestio ns regar ing this draft do cu ent should be sub itted wit in 9 0 days of publication in the Federal Register of the notice announcing the availability of the draft guidance Subm it comments to the D ivision of Dockets Manage e Comments and suggestions regarding this draft document should be submitted within 60 days of publication in the Federal Register of the notice announcing the availability of the draft guidance Submit electronic comments to httpwwwregulationsgov Sub 1061 Rockville MD 20852 All comments should be identified with the docket number listed in the notice of availability that is published in the Federal Register For questions rega rding this document contact Michael Ortwerth at 301 796 8220 US Depart Bla bla bla blab bla bla bla blab bla bla bla blab bla bla bla blab bla bla bla blab bla bla bla blab bla bla bla blab bla bla bla blab bla bla bla blab bla bla bla blab bla bla bla blab bla bla bla blab bla bla bla blab bla bla bla blab bla bla bla Representative: First Last. Date: . February . 4. , 2015. Location: . Misc. . Conference Room. Management Review Agenda. Roll Call of Attendees (5.6.1). Suitability of Quality Policy (5.3e). Status of Quality Objectives (. Combination Code and Task Profile Procedures 1 This document is intended to assist you with the combination code load process and task profile additions. 2 Adding a New Combination Code Fill out the INF46 Spreadsheet (sample layout below). and FDA Staff Class II Special Controls Guidance Document Surgical Sutures Guidance for Industry and FDA Document issued on June 3 2003 This document supersedes 147Class II Special Controls Guidance